# A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer

> **NCT00512681** · PHASE2 · COMPLETED · sponsor: **National Cancer Center, Korea** · enrollment: 44 (estimated)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **DRUG:** Irinotecan, Oxaliplatin, TS-1

## Key facts

- **NCT ID:** NCT00512681
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2009-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00512681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00512681, "A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00512681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*